I'm low-key worried about Novo Nordisk's situation 
. As someone who cares about healthcare and accessibility, I think it's a shame that weight-loss drug prices are being slashed by the government 
. I get that people need help losing weight, but shouldn't pharmaceutical companies be able to set their own prices? It feels like they're caught in the middle of everyone else's interests 
.
And can we talk about how this affects low-income communities and people with insurance? They might not have access to these new treatments or they'll end up paying more out-of-pocket
. I'm all for affordable healthcare, but is this really the right way to do it?
I wish companies like Novo Nordisk would invest in research and development that's focused on making their products more accessible, rather than just chasing profits
. We need a more sustainable model that prioritizes people over profit 
.
. As someone who cares about healthcare and accessibility, I think it's a shame that weight-loss drug prices are being slashed by the government . I get that people need help losing weight, but shouldn't pharmaceutical companies be able to set their own prices? It feels like they're caught in the middle of everyone else's interests .And can we talk about how this affects low-income communities and people with insurance? They might not have access to these new treatments or they'll end up paying more out-of-pocket
. I'm all for affordable healthcare, but is this really the right way to do it?I wish companies like Novo Nordisk would invest in research and development that's focused on making their products more accessible, rather than just chasing profits
. We need a more sustainable model that prioritizes people over profit .
. As someone who's been following their progress on Wegovy, I'm still optimistic about its potential. But it's crazy how quickly the market can shift, especially with Eli Lilly coming out strong with Mounjaro 
. I think we'll see more of this competition play out in 2026, and it's gonna be interesting to see how Novo Nordisk adjusts their strategy to stay ahead 
. Maybe they need to rethink their pricing or invest in new products? The future is uncertain, but one thing's for sure - the pharmaceutical industry won't be boring anytime soon 
. I mean, I get it, they're a big player in the pharma game and all that, but this whole pricing pressure thing is just a nightmare for them. It's like, they can't even keep up with Eli Lilly's new kid on the block, Mounjaro 
... I don't blame them, though. The pharmaceutical industry is super competitive right now. But, 17% one day and 50% the past year? That's a wild swing 
. On the bright side, their weight loss meds are still in demand (over 50k US prescriptions per week 
). Maybe they just need to get more aggressive with pricing... or develop some new meds to stay ahead of Eli Lilly 